SCHEMBL12795263

SCHEMBL12795263

C[C@@H]1CN([C@H]2CC[C@H](c3ccc(Nc4nc(-c5cncnc5)cc5cc[nH]c(=O)c45)cc3)CC2)CCO1

nearest known ligand 0.72

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ZAP70 P43403 18/20 0.72
JAK2 O60674 1/20 0.37
JAK1 P23458 1/20 0.37
SYK P43405 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1158610 1.00 ZAP70 (0.72) ZAP70JAK2JAK1SYK
SCHEMBL6525176 0.89 ZAP70 (0.73) ZAP70SYK
SCHEMBL12794986 0.89 ZAP70 (0.73) ZAP70SYK
SCHEMBL1160013 0.89 ZAP70 (0.73) ZAP70SYK
SCHEMBL1045674 0.88 ZAP70 (0.82) ZAP70
SCHEMBL1158193 0.86 ZAP70 (0.84) ZAP70JAK1SYK
SCHEMBL12795297 0.86 ZAP70 (0.84) ZAP70JAK1SYK
SCHEMBL1043307 0.84 ZAP70 (1.00) ZAP70JAK1
SCHEMBL1158619 0.84 ZAP70 (0.72) ZAP70JAK2SYK
SCHEMBL12794978 0.82 ZAP70 (0.62) ZAP70SYK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110053897-A1 COMPOUNDS AND COMPOSITIONS AS SYK KINASE INHIBITORS IRM LLC (BM) 2011-03-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110053897-A1 COMPOUNDS AND COMPOSITIONS AS SYK KINASE INHIBITORS SYK, BTK, LYN ZAP70 5/4885JAK2 19/4885JAK1 42/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.